Intrinsiqs

Is Filana Therapeutics, Inc. overvalued?

Filana Therapeutics, Inc. (FLNA) — key valuation metrics and fundamentals.

No verdict
Price
$0.91
Fair value
Current P/E
Normal P/E
Market cap
$44.1M
Dividend yield
0.0%
Return on equity
-58.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares FLNA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.